Furthermore, administration of an agonistic antibody against CD40 improves arthritis by the provision of IL-10 (Mauri et al., 2003; Evans et al., 2007) and IL-10 mediated TH1 inhibition (Mauri et al., 2000). This evidence concerns the gene IL10 and arthritic joint disease.